The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy

P. Fouqueray, V. Pirags, M. Diamant, G. Schernthaner, H.E. Lebovitz, S.E. Inzucchi, C.J. Bailey

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1924-1930
JournalDiabetes Care
Volume37
Issue number7
DOIs
Publication statusPublished - 2014

Cite this

Fouqueray, P., Pirags, V., Diamant, M., Schernthaner, G., Lebovitz, H. E., Inzucchi, S. E., & Bailey, C. J. (2014). The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy. Diabetes Care, 37(7), 1924-1930. https://doi.org/10.2337/dc13-2349
Fouqueray, P. ; Pirags, V. ; Diamant, M. ; Schernthaner, G. ; Lebovitz, H.E. ; Inzucchi, S.E. ; Bailey, C.J. / The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy. In: Diabetes Care. 2014 ; Vol. 37, No. 7. pp. 1924-1930.
@article{2f135c7d496245249f98f375bdd23825,
title = "The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy",
author = "P. Fouqueray and V. Pirags and M. Diamant and G. Schernthaner and H.E. Lebovitz and S.E. Inzucchi and C.J. Bailey",
year = "2014",
doi = "10.2337/dc13-2349",
language = "Undefined/Unknown",
volume = "37",
pages = "1924--1930",
journal = "Diabetes Care",
issn = "0149-5992",
publisher = "American Diabetes Association Inc.",
number = "7",

}

Fouqueray, P, Pirags, V, Diamant, M, Schernthaner, G, Lebovitz, HE, Inzucchi, SE & Bailey, CJ 2014, 'The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy' Diabetes Care, vol. 37, no. 7, pp. 1924-1930. https://doi.org/10.2337/dc13-2349

The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy. / Fouqueray, P.; Pirags, V.; Diamant, M.; Schernthaner, G.; Lebovitz, H.E.; Inzucchi, S.E.; Bailey, C.J.

In: Diabetes Care, Vol. 37, No. 7, 2014, p. 1924-1930.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Sitagliptin Monotherapy

AU - Fouqueray, P.

AU - Pirags, V.

AU - Diamant, M.

AU - Schernthaner, G.

AU - Lebovitz, H.E.

AU - Inzucchi, S.E.

AU - Bailey, C.J.

PY - 2014

Y1 - 2014

U2 - 10.2337/dc13-2349

DO - 10.2337/dc13-2349

M3 - Article

VL - 37

SP - 1924

EP - 1930

JO - Diabetes Care

JF - Diabetes Care

SN - 0149-5992

IS - 7

ER -